Legend Biotech Corporation vs UnitedHealth Group Incorporated — Stock Comparison
Legend Biotech Corporation (LEGN) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Legend Biotech Corporation narrowly edges UnitedHealth Group Incorporated on Q·Score (6.2 vs 6.1 out of 10), led by Valuation (9.6 vs 6.5) and Health (8.1 vs 5.3). UnitedHealth Group Incorporated scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for LEGN (+106.2%) than for UNH (+2.2%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $57.59 is 106% above current price.
⚠ currently unprofitable (-22% margin).
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
LEGN vs UNH: which stock scores better overall?
Based on Q·Score, Legend Biotech Corporation (LEGN) scores 6.2/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: LEGN or UNH?
Legend Biotech Corporation (LEGN) scores higher on Growth (5.8/10 vs 5.1/10). Legend Biotech Corporation reports revenue growth (56.5% YoY) while UnitedHealth Group Incorporated reports (2.0% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is LEGN or UNH more attractively valued?
Legend Biotech Corporation (LEGN) scores higher on Valuation (9.6/10 vs 6.5/10). LEGN trades at 20.9× P/E versus UNH at 19.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about LEGN vs UNH?
There are 15 analysts covering LEGN with a consensus price target of $57.59, and 26 analysts covering UNH with a consensus target of $409.77. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: LEGN or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Quality (5.9/10 vs 0.9/10). Net profit margin: LEGN at -22.0%, UNH at 2.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: LEGN or UNH?
Legend Biotech Corporation (LEGN) scores higher on Financial Health (8.1/10 vs 5.3/10). Market beta: LEGN at 0.35, UNH at 0.65. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of LEGN and UNH?
Legend Biotech Corporation (LEGN) has a market capitalisation of $5.2B, while UnitedHealth Group Incorporated (UNH) has a market cap of $364.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →